1357 related articles for article (PubMed ID: 31254236)
1. Metabolic syndrome, non-alcoholic fatty liver disease and liver stiffness in psoriatic arthritis and psoriasis patients.
Ortolan A; Lorenzin M; Tadiotto G; Russo FP; Oliviero F; Felicetti M; D'Incà R; Favero M; Piaserico S; Doria A; Ramonda R
Clin Rheumatol; 2019 Oct; 38(10):2843-2850. PubMed ID: 31254236
[TBL] [Abstract][Full Text] [Related]
2. Association of Non-alcoholic Fatty Liver Disease with Metabolic Syndrome Independently of Central Obesity and Insulin Resistance.
Yang KC; Hung HF; Lu CW; Chang HH; Lee LT; Huang KC
Sci Rep; 2016 Jun; 6():27034. PubMed ID: 27246655
[TBL] [Abstract][Full Text] [Related]
3. A cross-sectional study on the prevalence of metabolic syndrome in psoriasis compared to psoriatic arthritis.
Bostoen J; Van Praet L; Brochez L; Mielants H; Lambert J
J Eur Acad Dermatol Venereol; 2014 Apr; 28(4):507-11. PubMed ID: 24772493
[TBL] [Abstract][Full Text] [Related]
4. Systematic review and meta-analysis on prevalence of metabolic syndrome in psoriatic arthritis, rheumatoid arthritis and psoriasis.
Loganathan A; Kamalaraj N; El-Haddad C; Pile K
Int J Rheum Dis; 2021 Sep; 24(9):1112-1120. PubMed ID: 34076348
[TBL] [Abstract][Full Text] [Related]
5. Early diagnosis of psoriatic arthritis among psoriasis patients: clinical experience sharing.
Su YJ
Clin Rheumatol; 2020 Dec; 39(12):3677-3684. PubMed ID: 32468320
[TBL] [Abstract][Full Text] [Related]
6. Risk of liver disease in patients with psoriasis, psoriatic arthritis, and rheumatoid arthritis receiving methotrexate: A population-based study.
Gelfand JM; Wan J; Zhang H; Shin DB; Ogdie A; Syed MN; Egeberg A
J Am Acad Dermatol; 2021 Jun; 84(6):1636-1643. PubMed ID: 33607181
[TBL] [Abstract][Full Text] [Related]
7. Predictors for liver fibrosis in non-alcoholic patients with psoriatic diseases: A multicenter cross sectional-study.
Chavez-Tapia NC; Sanchez-Jimenez BA; Vidaña-Perez D; Corrales-Rosas B; Balderas-Garces B; Vera-Izaguirre D; Santa Cruz FJ; Maldonado-Garcia C; Juarez-Hernandez E; Uribe M
PLoS One; 2024; 19(4):e0290632. PubMed ID: 38626012
[TBL] [Abstract][Full Text] [Related]
8. [Predictors of liver fibrosis in patients with non-alcoholic fatty liver disease. The role of metabolic syndrome, insulin-resistance and inflammation].
Andreozzi P; Viscogliosi G; Colella F; Subic M; Cipriani E; Marigliano B; Verrusio W; Servello A; Ettorre E; Marigliano V
Recenti Prog Med; 2012 Dec; 103(12):570-4. PubMed ID: 23258240
[TBL] [Abstract][Full Text] [Related]
9. Liver Stiffness Measurement in Psoriasis: Do Metabolic or Disease Factors Play the Important Role?
Pongpit J; Porntharukchareon S; Kaewduang P; Promson K; Stitchantrakul W; Petraksa S; Thakkinstian A; Kositchaiwat C; Rajatanavin N; Sobhonslidsuk A
Biomed Res Int; 2016; 2016():7963972. PubMed ID: 27006950
[TBL] [Abstract][Full Text] [Related]
10. Risk of non-alcoholic fatty liver disease in patients with psoriasis: a systematic review and meta-analysis.
Candia R; Ruiz A; Torres-Robles R; Chávez-Tapia N; Méndez-Sánchez N; Arrese M
J Eur Acad Dermatol Venereol; 2015 Apr; 29(4):656-62. PubMed ID: 25418531
[TBL] [Abstract][Full Text] [Related]
11. Prevalence, characteristics and severity of non-alcoholic fatty liver disease in patients with chronic plaque psoriasis.
Miele L; Vallone S; Cefalo C; La Torre G; Di Stasi C; Vecchio FM; D'Agostino M; Gabrieli ML; Vero V; Biolato M; Pompili M; Gasbarrini G; Rapaccini G; Amerio P; De Simone C; Grieco A
J Hepatol; 2009 Oct; 51(4):778-86. PubMed ID: 19664838
[TBL] [Abstract][Full Text] [Related]
12. Risk of Incident Liver Disease in Patients with Psoriasis, Psoriatic Arthritis, and Rheumatoid Arthritis: A Population-Based Study.
Ogdie A; Grewal SK; Noe MH; Shin DB; Takeshita J; Chiesa Fuxench ZC; Carr RM; Gelfand JM
J Invest Dermatol; 2018 Apr; 138(4):760-767. PubMed ID: 29104161
[TBL] [Abstract][Full Text] [Related]
13. Risk of non-alcoholic fatty liver disease in patients with chronic plaque psoriasis: an updated systematic review and meta-analysis of observational studies.
Bellinato F; Gisondi P; Mantovani A; Girolomoni G; Targher G
J Endocrinol Invest; 2022 Jul; 45(7):1277-1288. PubMed ID: 35147926
[TBL] [Abstract][Full Text] [Related]
14. Serum adipokines in patients with psoriatic arthritis and psoriasis alone and their correlation with disease activity.
Eder L; Jayakar J; Pollock R; Pellett F; Thavaneswaran A; Chandran V; Rosen CF; Gladman DD
Ann Rheum Dis; 2013 Dec; 72(12):1956-61. PubMed ID: 23243196
[TBL] [Abstract][Full Text] [Related]
15. The effect of etanercept on hepatic fibrosis risk in patients with non-alcoholic fatty liver disease, metabolic syndrome, and psoriasis.
Campanati A; Ganzetti G; Di Sario A; Damiani A; Sandroni L; Rosa L; Benedetti A; Offidani A
J Gastroenterol; 2013 Jul; 48(7):839-46. PubMed ID: 23065020
[TBL] [Abstract][Full Text] [Related]
16. Association of Behçet disease with psoriasis and psoriatic arthritis.
Hahn HJ; Kwak SG; Kim DK; Kim JY
Sci Rep; 2021 Jan; 11(1):2531. PubMed ID: 33510251
[TBL] [Abstract][Full Text] [Related]
17. Prevalence and Predictors of Significant Fibrosis Among Subjects with Transient Elastography-Defined Nonalcoholic Fatty Liver Disease.
Lee HW; Kim BK; Kim SU; Park JY; Kim DY; Ahn SH; Kim KJ; Han KH
Dig Dis Sci; 2017 Aug; 62(8):2150-2158. PubMed ID: 28523578
[TBL] [Abstract][Full Text] [Related]
18. Screening for non-alcoholic fatty liver disease in patients with type 2 diabetes mellitus using transient elastography.
Lai LL; Wan Yusoff WNI; Vethakkan SR; Nik Mustapha NR; Mahadeva S; Chan WK
J Gastroenterol Hepatol; 2019 Aug; 34(8):1396-1403. PubMed ID: 30551263
[TBL] [Abstract][Full Text] [Related]
19. Enhanced liver fibrosis test in patients with psoriasis, psoriatic arthritis and rheumatoid arthritis: a cross-sectional comparison with procollagen-3 N-terminal peptide (P3NP).
van der Voort EAM; Wakkee M; Veldt-Kok P; Darwish Murad S; Nijsten T
Br J Dermatol; 2017 Jun; 176(6):1599-1606. PubMed ID: 27925155
[TBL] [Abstract][Full Text] [Related]
20. Clinical predictive score for detecting nonalcoholic fatty liver disease with significant fibrosis in patients with metabolic syndrome.
Kositamongkol C; Charernboon T; Chaisathaphol T; Washirasaksiri C; Auesomwang C; Sitasuwan T; Charatcharoenwitthaya P; Phisalprapa P
Medicine (Baltimore); 2021 Nov; 100(44):e27640. PubMed ID: 34871234
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
